Lorena Lerner
Chief Scientific OfficerDr. Lorena Lerner, Ph.D., is Chief Scientific Officer of Keros Therapeutics, Inc. from August 6, 2025 and served as its Senior Vice President of Research until August 6, 2025. Prior to that, Dr. Lerner served as our Senior Vice President, Research since January 2024 and as our Vice President, Research beginning in May 2022. From September 2017 to May 2022, Dr. Lerner held multiple positions of increasing responsibility at Oncorus, Inc., including Senior Director, Molecular Biology from September 2017 to December 2018, Vice President, Molecular Biology from January 2019 to November 2021 and Vice President, Research from December 2021 to May 2022. Prior to Oncorus, Inc., Dr. Lerner worked at Quiet Therapeutics from 2016 to 2017, at Scholar Rock Holding Corporation from 2015 to 2016 and at AVEO Pharmaceuticals, Inc. from 2003 to 2015. Dr. Lerner received an M.S. in Molecular Biology and a Ph.D. in Biochemistry from the University of Buenos Aires. She completed her postdoctoral work at the Rockefeller University.
Positions
- Company NameKeros Therapeutics, Inc.Stock CodeKROSPositionChief Scientific OfficerColleagues
- JSJasbir S. SeehraPresident, CEO & Director
- JBJean-Jacques BienaimeIndependent Chair of the Board
- ECEsther ChoChief Legal Officer & Secretary
- ATAnnita TaniniVP of Finance, Corporate Controller and Interim Principal Financial & Accounting Officer
- JFJustin FrantzHead of Investor Relations
- MAMary Ann GrayIndependent Director
- AHAlpna Hansraj SethIndependent Director
- JKJulius KnowlesIndependent Director
